These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22570584)

  • 21. Oral mucositis in head and neck cancer: risk, biology, and management.
    Sonis ST
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylene Blue for the Treatment of Intractable Pain Associated with Oral Mucositis.
    Roldan CJ; Nouri K; Chai T; Huh B
    Pain Pract; 2017 Nov; 17(8):1115-1121. PubMed ID: 28226414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological modulation of radiation-induced oral mucosal complications.
    Bockel S; Vallard A; Lévy A; François S; Bourdis M; Le Gallic C; Riccobono D; Annede P; Drouet M; Tao Y; Blanchard P; Deutsch É; Magné N; Chargari C
    Cancer Radiother; 2018 Sep; 22(5):429-437. PubMed ID: 29776830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for treating oral mucositis for patients with cancer receiving treatment.
    Clarkson JE; Worthington HV; Furness S; McCabe M; Khalid T; Meyer S
    Cochrane Database Syst Rev; 2010 Aug; 2010(8):CD001973. PubMed ID: 20687070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.
    Vigarios E; Epstein JB; Sibaud V
    Support Care Cancer; 2017 May; 25(5):1713-1739. PubMed ID: 28224235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for treating oral mucositis for patients with cancer receiving treatment.
    Clarkson JE; Worthington HV; Eden OB
    Cochrane Database Syst Rev; 2007 Apr; (2):CD001973. PubMed ID: 17443514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Therapeutic Effects of Gut Hormones, Ghrelin and Obestatin in Oral Mucositis.
    Stempniewicz A; Ceranowicz P; Warzecha Z
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
    Karagözoğlu S; Filiz Ulusoy M
    J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury.
    Cinausero M; Aprile G; Ermacora P; Basile D; Vitale MG; Fanotto V; Parisi G; Calvetti L; Sonis ST
    Front Pharmacol; 2017; 8():354. PubMed ID: 28642709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis.
    Thomsen M; Vitetta L
    Integr Cancer Ther; 2018 Dec; 17(4):1027-1047. PubMed ID: 30136590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for treating oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2004; (2):CD001973. PubMed ID: 15106165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT.
    Nugent M; Bryant V; Butcher C; Fisher H; Gill S; Goranova R; Hiu S; Lindley L; O'Hara J; Oluboyede Y; Patterson J; Rapley T; Robinson T; Rousseau N; Ryan V; Shanmugasundaram R; Sharp L; Smith Whelan R; Stocken DD; Ternent L; Wilson J; Walker J
    Health Technol Assess; 2022 Dec; 26(46):1-172. PubMed ID: 36484364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Clarkson JE; Worthington HV; Eden OB
    Cochrane Database Syst Rev; 2003; (3):CD000978. PubMed ID: 12917895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
    Sayed R; El Wakeel L; Saad AS; Kelany M; El-Hamamsy M
    Med Oncol; 2019 Nov; 37(1):8. PubMed ID: 31748905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol), a concentrated oral gel wafer, in the treatment of oral mucositis.
    Naidu MU; Ramana GV; Ratnam SV; Sudhavani T; Naidu KJ; Roy P; Suresh P; Rani PU; Mohan IK
    Drugs R D; 2005; 6(5):291-8. PubMed ID: 16128599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.
    Saadeh CE
    Pharmacotherapy; 2005 Apr; 25(4):540-54. PubMed ID: 15977916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineral derivatives in alleviating oral mucositis during cancer therapy: a systematic review.
    Lee S
    PeerJ; 2015; 3():e765. PubMed ID: 25699212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer.
    Naidu MU; Ramana GV; Rani PU; Mohan IK; Suman A; Roy P
    Neoplasia; 2004; 6(5):423-31. PubMed ID: 15548350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.